Hangzhou Minsheng Healthcare Co Ltd Total Liabilities

Latest as of June 2026: CN¥371.98 Million CNY ≈ $54.43 Million USD

Hangzhou Minsheng Healthcare Co Ltd total liabilities. Based on the latest financial reports, Hangzhou Minsheng Healthcare Co Ltd (301507) has total liabilities worth CN¥371.98 Million CNY (≈ $54.43 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 301507 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Hangzhou Minsheng Healthcare Co Ltd (2021–2025)

Total liabilities of Hangzhou Minsheng Healthcare Co Ltd from 2021 to 2025. This chart illustrates how Hangzhou Minsheng Healthcare Co Ltd's total liabilities have evolved over time, based on quarterly financial data.

Hangzhou Minsheng Healthcare Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou Minsheng Healthcare Co Ltd ranked by their total liabilities.

Company Country Total Liabilities
Sagimet Biosciences Inc. Series A Common Stock
NASDAQ:SGMT
USA $7.28 Million
Shenzhen Sinovatio Technology Co Ltd Class A
SHE:002912
China CN¥337.24 Million
Zhejiang Langdi Group Co Ltd
SHG:603726
China CN¥1.39 Billion
PIMCO Access Income Fund
NYSE:PAXS
USA $498.03 Million
Civista Bancshares Inc
NASDAQ:CIVB
USA $3.79 Billion
Mercuries & Associates Holding Ltd
TW:2905
Taiwan NT$1.52 Trillion
Jiangxi Sunshine Dairy Co Ltd
SHE:001318
China CN¥77.85 Million
Farglory FTZ Investment Holding Co Ltd
TW:5607
Taiwan NT$16.67 Billion

Liability Composition Analysis (2021–2025)

This chart breaks down Hangzhou Minsheng Healthcare Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Hangzhou Minsheng Healthcare Co Ltd (301507) total assets.

Liquidity & Leverage Metrics

Hangzhou Minsheng Healthcare Co Ltd Total Liabilities Ratios Explained

Hangzhou Minsheng Healthcare Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.05 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.23 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.18 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Minsheng Healthcare Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Minsheng Healthcare Co Ltd (2021–2025)

The table below shows the annual total liabilities of Hangzhou Minsheng Healthcare Co Ltd from 2021 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥298.60 Million
≈ $43.69 Million
+39.69%
2024-12-31 CN¥213.76 Million
≈ $31.28 Million
+22.32%
2023-12-31 CN¥174.75 Million
≈ $25.57 Million
+2.10%
2022-12-31 CN¥171.16 Million
≈ $25.05 Million
+2.88%
2021-12-31 CN¥166.37 Million
≈ $24.34 Million
--

About Hangzhou Minsheng Healthcare Co Ltd

SHE:301507 China Drug Manufacturers - General
Market Cap
$596.36 Million
CN¥4.08 Billion CNY
Market Cap Rank
#11007 Global
#2991 in China
Share Price
CN¥11.43
Change (1 day)
+1.24%
52-Week Range
CN¥11.29 - CN¥17.79
All Time High
CN¥32.51
About

Hangzhou Minsheng Healthcare Co., Ltd. engages in the research, development, production, and sale of vitamins and mineral supplements, OTC drugs, and healthy foods in China and internationally. The company offers healthy products, such as fish and algae oil gel candy, collagen peptide vitamin D calcium chewable tablets, blueberry lutein ester candy tablets, and probiotic solid beverage. It also p… Read more